UK Parliament / Open data

Breast Cancer Drugs

Proceeding contribution from Nick Thomas-Symonds (Labour) in the House of Commons on Thursday, 26 January 2017. It occurred during Backbench debate on Breast Cancer Drugs.

I understand that a new policy is being put together by those in charge of the “British National Formulary”, which will set out how they will get more off-label drugs into the formulary. Does my hon. Friend agree that the sooner that policy is available for us to see the better?

Type
Proceeding contribution
Reference
620 c519 
Session
2016-17
Chamber / Committee
House of Commons chamber
Back to top